| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/13/2023 | Cidara Therapeutics, Inc. | CDTX | Sale | Common Stock | 6.6k | $1.53 | $10.2k | | 03/13/2023 |
| 09/19/2022 | Cidara Therapeutics, Inc. | CDTX | Sale | Common Stock | 15.6k | $0.77 | $12k | | 09/15/2022 |
| 09/15/2022 | Cidara Therapeutics, Inc. | CDTX | Exercise | Restricted Stock Unit | 50k | $0.00 | $0 | | 09/15/2022 |
| 03/31/2022 | Cidara Therapeutics, Inc. | CDTX | Grant | Common Stock | 51.2k | $0.00 | $0 | | 03/31/2022 |
| 03/31/2022 | Cidara Therapeutics, Inc. | CDTX | Grant | Common Stock | 66k | $0.00 | $0 | | 03/31/2022 |
| 03/31/2022 | Cidara Therapeutics, Inc. | CDTX | Payment of Exercise | Common Stock | 24.8k | $0.83 | $20.6k | | 03/31/2022 |
| 03/31/2022 | Cidara Therapeutics, Inc. | CDTX | Grant | Employee Stock Option (right to buy) | 102.5k | $0.83 | $85.1k | | 03/31/2022 |
| 11/12/2021 | Cidara Therapeutics, Inc. | CDTX | Purchase | Common Stock | 20k | $1.54 | $30.8k | | 11/12/2021 |
| 09/01/2021 | Cidara Therapeutics, Inc. | CDTX | Grant | Restricted Stock Unit | 50k | $0.00 | $0 | | 09/01/2021 |
| 09/01/2021 | Cidara Therapeutics, Inc. | CDTX | Grant | Stock Option (right to buy) | 311.8k | $2.22 | $692.3k | | 09/01/2021 |
| 12/30/2020 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Payment of Exercise | Common Stock | 25k | $4.64 | $116k | | 12/30/2020 |
| 12/24/2019 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Purchase | Common Stock | 11.6k | $3.96 | $45.9k | | 12/24/2019 |
| 09/06/2019 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Grant | Stock Option (right to buy) | 100k | $6.00 | $600k | | 09/06/2019 |
| 09/06/2019 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Grant | Stock Option (right to buy) | 100k | $3.96 | $396k | | 09/06/2019 |
| 09/06/2019 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Grant | Common Stock | 25k | $0.00 | $0 | | 09/06/2019 |